07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Authors: M. ELIAVA 1 , *V. GRINEVICH 4 , P. N. LACOR 2 , R. VASSAR 3 , W. L. KLEIN 2 , P.<br />

OSTEN 1 ;<br />

1 Physiol., 2 Neurobio. and Physiol., 3 Cell and Mol. Biol., Northwestern Univ., Chicago, IL; 4 Mol.<br />

Neurobiol., Max Planck Inst. Med. Res., Heidelberg, Germany<br />

<strong>Abstract</strong>: Soluble amyloid-β (Aβ) oligomers have been proposed to critically contribute to early<br />

pathology of Alzheimer‟s disease (AD), especially to deficits in synaptic plasticity that may<br />

underlie memory impairments. However, whereas the evidence <strong>for</strong> pathological function of<br />

exogenously applied Aβ oligomers is well documented, little is known about how Aβ oligomers<br />

are <strong>for</strong>med in the brain. For example, it is not known whether Aβ oligomerization occurs<br />

intraneuronally following β- and γ-secretase-mediated proteolysis of amyloid precursor protein<br />

(APP) or whether Aβ oligomers are <strong>for</strong>med from secreted Aβ monomers extracellularly. Here we<br />

examine this question in two AD mouse models, 5XFAD mice with rapid Aβ accumulation due<br />

to expression of five FAD mutations (APP Swedish, Florida and London and presenilin-1<br />

M146L and L286V) and Tg2576 mice with much slower Aβ accumulation from expression of a<br />

single APP Swedish FAD mutation. We take advantage of a mosaic expression pattern common<br />

to most transgenic mice and ask whether neurons with high expression of the APP transgene also<br />

show high accumulation of intraneuronal monomeric and oligomeric Aβ, as would be expected<br />

from direct intraneuronal processing. These experiments are done by double-labeling<br />

immunohistochemistry, with 1) APP N- or C-terminal-specific antibodies applied to detect the<br />

level of APP transgene expression, and 2) Aβ40-, Aβ42- and Aβ oligomer-specific antibodies<br />

used to detect the level of intraneuronal accumulation of the respective Aβ <strong>for</strong>ms. Our<br />

preliminary data suggest a close correlation between APP expression and intraneuronal<br />

accumulation of oligomeric Aβ <strong>for</strong>ms. Furthermore, cortical neurons previously shown to be<br />

highly vulnerable to cell death in the 5XFAD model show the highest expression of APP and<br />

accumulation of Aβ oligomers. This suggests that Aβ oligomers <strong>for</strong>med intraneuronally may<br />

directly contribute to AD neurotoxicity.<br />

Disclosures: M. Eliava, None; V. Grinevich , None; P.N. Lacor, None; R. Vassar,<br />

None; W.L. Klein, None; P. Osten, None.<br />

Poster<br />

243. Abeta Assembly and Deposition<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 243.5/J11<br />

Topic: C.01.b. Abeta assembly and deposition<br />

Support: NIH Grant AG18879

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!